Related content

Carmustine Wafers (Gliadel) Plus Concomitant Temozolomide Therapy After Resection of Malignant Astrocytoma: Growing Evidence for Safety and Efficacy

By McGirt Matthew  

Annals of Surgical Oncology, Vol. 17, Iss. 7, 2010-07 ,pp. : 1729-1731

Springer Publishing Company

Access to resources Recommend Favorite

Monitoring the effects of BCNU chemotherapy Wafers (Gliadel^®) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla

By Dyke Jonathan   Sanelli Pina   Voss Henning   Serventi Jennifer   Stieg Philip   Schwartz Theodore   Ballon Douglas   Shungu Dikoma   Pannullo Susan  

Journal of Neuro-Oncology, Vol. 82, Iss. 1, 2007-03 ,pp. : 103-110

Springer Publishing Company

Access to resources Recommend Favorite

Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience

By Attenello Frank  

Annals of Surgical Oncology, Vol. 15, Iss. 10, 2008-10 ,pp. : 2887-2893

Springer Publishing Company

Access to resources Recommend Favorite

Pattern of Recurrence following Local Chemotherapy with Biodegradable Carmustine (BCNU) Implants in Patients with Glioblastoma

By Giese Alf   Kucinski Thomas   Knopp Ulrich   Goldbrunner Roland   Hamel Wolfgang   Mehdorn H.M.   Tonn Jörg C.   Hilt Dana   Westphal Manfred  

Journal of Neuro-Oncology, Vol. 66, Iss. 3, 2004-02 ,pp. : 351-360

Springer Publishing Company

Access to resources Recommend Favorite

A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme

By Limentani Steven   Asher Anthony   Heafner Michael   Kim Joseph   Fraser Robert  

Journal of Neuro-Oncology, Vol. 72, Iss. 3, 2005-05 ,pp. : 241-244

Springer Publishing Company

Access to resources Recommend Favorite